Tumour necrosis factor alpha as a therapeutic target for immune-mediated inflammatory diseases.

Preclinical studies have identified and validated tumour necrosis factor alpha (TNFalpha) as a key disease molecule and therapeutic target for immunotherapeutic intervention in many immune-mediated inflammatory diseases. Clinical indications include rheumatoid arthritis, Crohn's disease, ankylo...

全面介绍

书目详细资料
Main Authors: Taylor, P, Williams, R, Feldmann, M
格式: Journal article
语言:English
出版: 2004

相似书籍